Browsing "1. Journal Papers" by Author : 3817

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 53 of 53

This table browses all dspace content
Issue DateTitleJournal Title
200920대 이하 간세포암종의 증례 : 20세 미만의 젊은 연령에서 발병한 간세포암종 1예 Journal of the Korean Liver Cancer Study Group (대한간암연구회지)
20043차원 입체조형치료에 의한 아교모세포종의 방사선 선량증가 연구 Journal of the Korean Society for Therapeutic Radiology and Oncology
2020A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage Brain Tumor Research and Treatment
2020A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma Brain Tumor Research and Treatment
2020A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma Brain Tumor Research and Treatment
2022Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study FRONTIERS IN ONCOLOGY
2022An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas RADIATION ONCOLOGY
2019Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningiomaJournal of Neuro-Oncology
2020ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data RADIATION ONCOLOGY
2011Brain metastases from colorectal carcinoma: prognostic factors and outcomeJOURNAL OF NEURO-ONCOLOGY
2020Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection?JOURNAL OF NEURO-ONCOLOGY
2019Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era RADIATION ONCOLOGY
2017Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea CANCER RESEARCH AND TREATMENT
2014Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.ANNALS OF HEMATOLOGY
2017Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients CANCER RESEARCH AND TREATMENT
2021Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle FRONTIERS IN ONCOLOGY
2020Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma SCIENTIFIC REPORTS
2014Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report YONSEI MEDICAL JOURNAL
2024High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma YONSEI MEDICAL JOURNAL
2018Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival YONSEI MEDICAL JOURNAL
2018Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY
2023Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiformeJOURNAL OF NEURO-ONCOLOGY
2019Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous SystemNEUROSURGERY
2017Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy SCIENTIFIC REPORTS
2017Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis. MEDICINE
2012MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY
2018Multiple systemic extraneural metastasis of glioblastomaCHIRURGIA
2023Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter StudyNEUROSURGERY
2017Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation statusRADIOTHERAPY AND ONCOLOGY
2017Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study RADIATION ONCOLOGY JOURNAL
2019Patterns of failures after surgical resection in olfactory neuroblastomaJOURNAL OF NEURO-ONCOLOGY
2022Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective studyJOURNAL OF NEUROSURGERY
2020Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)RADIOTHERAPY AND ONCOLOGY
2017Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma ONCOTARGET
2016Pseudoprogression in glioblastoma patients: the impact of extent of resectionJOURNAL OF NEURO-ONCOLOGY
2016Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors. YONSEI MEDICAL JOURNAL
2018Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification SCIENTIFIC REPORTS
2019Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classificationJOURNAL OF NEUROSURGERY
2020Survival benefit of lobectomy over gross-total resection without lobectomy in cases of primary glioblastoma in non-eloquent area: a retrospective studyJOURNAL OF NEUROSURGERY
2020Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas CANCER RESEARCH AND TREATMENT
2024The importance of considering competing risks in recurrence analysis of intracranial meningioma JOURNAL OF NEURO-ONCOLOGY
2021The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1 Brain Tumor Research and Treatment
2021The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1 Brain Tumor Research and Treatment
2019The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01 Brain Tumor Research and Treatment
2019The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01 Brain Tumor Research and Treatment
2019The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01 Brain Tumor Research and Treatment
2017The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphomaANNALS OF HEMATOLOGY
2022The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11) CANCER RESEARCH AND TREATMENT
2016The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphomaBRITISH JOURNAL OF HAEMATOLOGY
2019Treatment outcomes of radiotherapy for primary spinal cord gliomaSTRAHLENTHERAPIE UND ONKOLOGIE
2020Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastomaSTRAHLENTHERAPIE UND ONKOLOGIE
2018Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative studyRADIOTHERAPY AND ONCOLOGY
1

Browse

Links